Background New drug treatments, clinical trials, and standards of quality for assessment of
evidence justify an update of evidence-based recommendations for the pharmacological …

Neuropathic pain is triggered by lesions to the somatosensory nervous system that alter its
structure and function so that pain occurs spontaneously and responses to noxious and …

Pain usually results from activation of nociceptive afferents by actually or potentially tissue-
damaging stimuli. Pain may also arise by activity generated within the nervous system …

Few studies have directly compared the clinical features of neuropathic and non-
neuropathic pains. For this purpose, the French Neuropathic Pain Group developed a …

Objective: Nociceptive and neuropathic components both contribute to pain. Since these
components require different pain management strategies, correct pain diagnosis before …

The nationwide multicenter trials of the German Research Network on Neuropathic Pain
(DFNS) aim to characterize the somatosensory phenotype of patients with neuropathic pain …

We conducted a large nationwide postal survey to estimate the prevalence of chronic pain
with or without neuropathic characteristics in the French general population. A questionnaire …

Patients with neuropathic pain (NP) are challenging to manage and evidence-based clinical
recommendations for pharmacologic management are needed. Systematic literature …

Neuropathic pain is a chronic condition representing a significant burden for patients,
society, and healthcare systems. The prevalence of neuropathic pain in the general …

Nociceptive pain results from the detection of intense or noxious stimuli by specialized high-
threshold sensory neurons (nociceptors), a transfer of action potentials to the spinal cord …